Regenerative medicine, or the use of specially grown tissues and cells to treat injuries and diseases, has been successful in treating disorders of a number of organs, including heart, pancreas, and cartilage. However, efforts ...
Jun 14, 2012
0
0
A new drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in ...
Oct 26, 2023
0
0
Corneal diseases are among the most common causes of visual impairment and blindness, with Fuchs endothelial corneal dystrophy (FECD), a gradual swelling and clouding of the cornea, being the most common reason for eventual ...
Mar 31, 2017
0
22
A UCSF study gives hope to those suffering from severe cases of bacterial corneal ulcers, which can lead to blindness if left untreated. The use of topical corticosteroids in a randomized controlled trial was found to be ...
Oct 18, 2011
0
0
(Medical Xpress) -- Vision scientist Royce Mohan is focusing in on a treatment for corneal fibrosis, an irreversible pathogenic mechanism associated with the second-leading cause of blindness in the world. The cornea is the ...
Dec 13, 2011
0
0
A biocompatible, antimicrobial adhesive for corneal repair and grafting could replace sutures and conventional adhesives with bad side effects.
Dec 6, 2021
0
1
After an injury to tissues, such as in organ transplantation, the body grows new lymphatic vessels in a process known as lymphangiogenesis. A new study in Nature Communications reveals a mechanism involved in the regulation ...
Apr 12, 2016
0
123
(Medical Xpress) -- A new study from the University of Reading has established that a prosthetic cornea made from human cells is the best model for testing how irritants and toxins cause eye injuries.
May 28, 2012
0
0
Researchers are testing cutting-edge treatments for people who want to see up close without reading glasses and finding promising results, according to studies presented this week at AAO 2016, the 120th annual meeting of ...
Oct 18, 2016
0
1
Participants in a phase I/II clinical trial of a new enzyme-based treatment for severe dry eye disease experienced reduced signs of disease and discomfort, according to a paper in Translational Vision Science and Technology.
May 7, 2019
0
4
